SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB


              [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                  For the quarterly period ended June 30, 2001
                  --------------------------------------------

               [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF
                                THE EXCHANGE ACT

              For the period from ______________ to ______________


                         Commission file number 0-26445
                                                -------


                        ACCESS HEALTH ALTERNATIVES, INC.
                        --------------------------------
        (Exact name of small business issuer as specified in its charter)


                   Florida                             59-3542362
         ----------------------------             ------------------
         (State of other jurisdiction              (IRS Employer
       of incorporation or organization)          Identification No.)


                2016 South Orange Avenue, Orlando, Florida 32806
                ------------------------------------------------
                    (Address of principal executive offices)


                                 (407) 423-4799
                           ---------------------------
                           (Issuer's Telephone Number)


        ----------------------------------------------------------------
              (Former name, former address and former fiscal year,
                         if changed since last report)


                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                   PROCEEDINGS DURING THE PRECEDING FIVE YEARS

Check whether the registrant filed all documents and reports required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the distribution of
securities under a plan confirmed by a court. Yes [ ] No [ ]


                      APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date.

     9,860,617 shares of the Issuer's $.001 par value common stack were
     outstanding as of as of August 9, 2001.

Transitional Small  Business Disclosure Format (Check one)  Yes [ ]  No [X]


                                      -1-

<PAGE>

                                     PART I

Item 1.  FINANCIAL STATEMENTS


                        Access Health Alternatives, Inc.
                     Consolidated Balance Sheet (Unaudited)


<TABLE>
<CAPTION>
                                                          Consolidated         Consolidated
                                                            6/30/2001           12/31/2000
                                                          -------------        ------------
<S>                                                       <C>                   <C>

Assets
Current Assets-
   Cash                                                    $     1,985          $     6,919
   Trade receivables, net                                      281,759              243,698
   Inventories                                                  94,090               99,369
   Other current assets                                        342,824               24,472
                                                           ------------         ------------
         Total current assets                                  720,658              374,458

Property & Equipment, net                                      107,760              125,248
Goodwill                                                     2,349,092                    0
Other Assets                                                   798,821              625,382
                                                           ------------         ------------
         Total Assets                                      $ 3,976,331          $ 1,125,088
                                                           ============         ============

Liabilities
Current Liabilities-
   Notes and commercial paper                                1,588,091            1,641,834
   Line of Credit                                              100,000              100,000
   Current installment of long-term debt                        45,434               37,704
   Current obligation under capital lease                       63,864               84,286
   Bank overdraft                                               89,418               60,925
   Accounts payable                                            938,481              815,744
   Accrued liabilities                                       1,047,148            1,022,419

   Due to related parties:
      Stockholders                                             470,058              462,242
      Limited liability companies                            1,592,612            1,592,612
                                                           ------------         ------------
         Total due to related parties                        2,062,670            2,054,854
                                                           ------------         ------------
             Total current liabilities                       5,935,106            5,817,766
                                                           ------------         ------------

Unearned income                                                156,259              196,370
Obligation under capital lease, less current portion            65,402               82,663
Long-term portion of note payable                              713,770              631,780
Minority interest in subsidiary                                113,455              113,455
                                                           ------------         ------------
             Total Liabilities                               6,983,992            6,842,034
                                                           ------------         ------------

Stockholders' Deficit
Common stock                                                     9,895                4,427
Preferred stock                                                 62,305                    0
Capital in excess of par value                               3,746,268            2,939,981
Accumulated deficit                                         (6,826,129)          (8,661,354)
                                                           ------------         ------------
             Total stockholders' deficit                    (3,007,661)          (5,716,946)
                                                           ------------         ------------
             Total liabilities & stockholders' deficit     $ 3,976,331          $ 1,125,088
                                                           ============         ============
</TABLE>

                See notes to consolidated financial statements.


                                      -2-

<PAGE>
                        Access Health Alternatives, Inc.
                Consolidated Statement of Operations - Unaudited
                                   (unaudited)


<TABLE>
<CAPTION>
                                                      Three months ended                     Six months ended
                                                            June 30,                              June 30,
                                                         -------------                          ------------
                                                    2001               2000               2001               2000
                                                ---------------------------------------------------------------------

<S>                                             <C>                <C>                <C>                    <C>
Revenues-
   Equipment                                    $        -         $        -         $        -        $         -
   Products                                          33,824             42,989             81,872             99,401
   Provider payments                                 87,667            180,838            233,702            389,906
   Service fees                                      81,614            106,693            239,430            229,700
   Other (net)                                      483,421            685,864            934,442          1,276,713
                                                ---------------------------------------------------------------------

      Total revenues                                686,526          1,016,384          1,489,446          1,995,720

Cost of sales-
   Equipment                                              0                  0                  0                  0
   Products                                           5,687              6,567             15,760             23,080
   Other                                              8,579             29,763             10,681             29,763
                                                ---------------------------------------------------------------------

      Total cost of sales                            14,266             36,330             26,441             52,843
                                                ---------------------------------------------------------------------

           Gross profit                             672,260            980,054          1,463,005          1,942,877

Selling, general & administrative expenses         (857,243)          (964,475)        (1,901,729)        (2,220,647)
                                                ---------------------------------------------------------------------

           Operating income/(loss)                 (184,983)             15,579          (438,724)          (277,770)

Other Expenses
   Interest expense                                 (40,335)           (60,173)          (101,116)          (124,234)
   Other, net                                       (16,000)             1,819            (32,000)            (1,431)
                                                ---------------------------------------------------------------------
           Net income/(loss)                    $  (241,318)       $   (42,775)       $  (571,840)       $  (403,435)
                                                =====================================================================

Basic net loss per share                         $    (0.02)        $    (0.00)        $    (0.06)        $    (0.04)
                                                ---------------------------------------------------------------------

</TABLE>

                See notes to consolidated financial statements.

                                      -3-

<PAGE>
                        Access Health Alternatives, Inc.
                Consolidated Statement of Cash Flows (Unaudited)


<TABLE>
<CAPTION>
                                                                Three Months Ended              Six Months Ended
                                                                      June 30,                       June 30,
                                                                  -------------                    -----------
                                                              2001             2000            2001           2000
                                                           -----------------------------------------------------------
<S>                                                      <C>              <C>              <C>             <C>

Cash flows from operating activities:
  Net loss                                               $ (241,319)      $  (42,775)      $ (571,840)     $(403,435)
  Adjustment to reconcile net loss to net cash provided
    by (used in) operating activities:
       Depreciation and amortization                          10,935           12,634           21,870         25,658
       Losses of limited liability companies                     -                -                -
       Unearned income recognized                            (20,611)         (18,361)         (40,111)       (39,000)
       Issuance of common stock for services                     -                -            347,000            -
       Cash provided by (used in) changes in:
          Receivables                                         (1,303)         (96,212)         (38,254)      (185,083)
          Inventories                                          5,687            6,567            5,279         23,080
          Other assets                                         9,999              -           (477,760)       (36,324)
          Bank overdraft                                       3,933             (953)          31,068        (12,590)
          Accounts payable                                   135,770           26,044          122,737        (37,913)
          Accrued liabilities                                (11,624)          96,005           17,617        371,972
                                                         -------------------------------------------------------------

          Net cash used in operating activities             (108,533)         (17,051)        (582,394)      (293,635)
Cash flows from investing activities:
  Purchases of property and equipment                         (2,107)             -             (4,382)           -
                                                         -------------------------------------------------------------

Cash flows from financing activities:
  Payments on notes and commercial paper                      (6,665)             913          (53,743)           -
  Proceeds from notes and commercial paper                    49,598           17,737           89,720        549,366
  Due to stockholders                                          6,100          (15,000)           7,816       (113,938)
  Advances (to) from limited liability companies                 -                -                -          (78,213)
  Due to related party                                           -             19,120              -              -
  Payments on capital lease obligations                      (19,401)          (1,303)         (37,683)       (59,946)
  Goodwill                                                    16,000              -         (2,365,092)           -
  Proceeds from issuance of stock                             62,305              -          2,943,399            100
                                                         -------------------------------------------------------------

         Net cash provided by financing activities           107,937           21,467          584,417        297,369
                                                         -------------------------------------------------------------
  Net (decrease) increase in
  cash                                                        (2,703)           4,416           (2,359)         3,734

         Cash at beginning of period                           4,688            1,112            4,344          1,794
                                                         -------------------------------------------------------------
         Cash at end of period                            $    1,985       $    5,528       $    1,985      $   5,528
                                                         =============================================================

</TABLE>



                See notes to consolidated financial statements.

                                      -4-

<PAGE>
                         ACCESS HEALTH ALTERNATIVES, INC
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 2001


(1)  Basis of Presentation

     In the opinion of the management, the accompanying unaudited interim
     consolidated financial statements include all adjustments necessary to
     present fairly the financial position of the Company, the results of its
     operations and changes in cash flows for the interim periods reported.
     These adjustments are of a normal recurring nature. All financial
     statements presented herein are unaudited. However, the balance sheet as of
     December 31, 2000, was derived from the audited consolidated balance sheet.
     These statements should be read in conjunction with the financial
     statements included in the Company's annual report on Form 10-KSB for the
     year ended December 31, 2000. The results of operations for the interim
     periods shown in this report are not necessarily indicative of results to
     be expected for the fiscal year.


(2)  Litigation

     The Company is a nominal defendant in several legal actions. While the
     results of these actions cannot be predicted with certainty, the Company
     believes that the final outcome of such litigation will not have a
     materially adverse effect on its financial condition.


(3)  Contingency

     At June 30, 2001, the Company has suffered recurring losses and has a net
     capital deficiency of $3,007,661 and a working capital deficiency of
     $5,214,448, which raises substantial doubt about its ability to continue as
     a going concern. The Company is actively pursuing a private offering of
     securities and a debt restructuring as a means of raising funds to rectify
     its capital deficiency and implement its business plan.


(4)  Additional Corporate Events

     On December 28, 2000, the Company entered into an agreement to issue
     1,800,000 shares of stock to a corporate investor for $500,000 payable,
     $250,000 on January 31, 2001 and $250,000 on February 28, 2001. The Company
     has not received the installments due under the contract. In January 2001,
     the Company issued 660,000 shares of common stock to an individual
     affiliated with the corporate investor, for corporate relations and public
     relations services to be performed in 2001. In April 2001 the Company
     notified the investor that both agreements were being rescinded and
     demanded return of all shares.

     In June 2001, the Company sold 2.5 units of "Series B Preferred Stock". The
     stock is convertible into common and does carry a dividend.


                                      -5-

<PAGE>

     In January 2001, the Company acquired two companies, Continua and EMDx
     (collectively, "EMDx"), subject to certain conditions. Both companies are
     owned by the same individuals and are located in Savannah, Georgia. Under
     the terms of the acquisition, the Company acquired 100% of the stock in
     each company for a total of 750,000 restricted shares. The acquisition will
     be accounted for as a purchase. The companies are involved in providing
     technology services to the healthcare industry and providing discounted
     medical lab services.

     In January 2001, the Company acquired a controlling interest in HealthCare,
     subject to certain conditions. Under the terms of the acquisition the
     Company will acquire 100% of the stock of Healthcare for 4,000,000
     restricted shares. The acquisition will be treated as a purchase.
     HealthCare operates a chiropractic group practice in Central Florida and
     has affiliated chiropractic practices throughout Florida.

     The acquisition agreements for Continua, EMDx and Healthcare contain
     provisions that should the Company fail to raise a minimum of $8,000,000
     within nine months of closing the acquisition, the shareholders may return
     the shares in the Company in return for 91% of the stock of Continua and
     EMDx and return of 100% of the stock of Healthcare.


                                      -6-

<PAGE>


ITEM  2.  MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OR  PLAN  OF  OPERATION.

The following discussion and analysis should be read in conjunction with the
financial statements of the Company and the accompanying notes appearing
previously under the caption "Financial Statements." In addition, previous
filings with the Securities and Exchange Commission by the Company may contain
information that readers will find important. The following discussion and
analysis contains forward-looking statements, which involve risks and
uncertainties. The Company's actual results may differ significantly from the
results, expectations and plans discussed in these forward-looking statements.

Results of Operations for the Period Ended June 30, 2001 compared with the
Period Ended June 30, 2000

Management believes that a comparison of the financial performance of the
Company in the three months ended June 30, 2001 and in the three months ended
June 30, 2000 shows the effects of the failed commitment regarding funding
activities which occurred earlier. This failed commitment caused senior
management to divert attention form growth and expansion and towards capital
raising.

Management continues to operate under the assumption that the raise of long term
capital will be accomplished. With this in mind discussions have been initiated
and are ongoing related to business relationships which will support the over
all mission of the Company. It is believed that certain agreements will be
consummated which will assist in fully implementing the Company's business plan
once the capital issues have been solved. The Company has never the less
suffered a significant delay in launching aspects of its business plan.
Furthermore, without the capital necessary the company will not be in a position
to replenish product inventory required to support the nutritional supplement
subsidiary. The subsidiary accounted for 4.9% of total revenue in the current
quarter and can be expected to decline further both as a percentage of total
revenue and in absolute terms.

A previously announced long term financing failed to materialize. The Company,
as previously stated, initiated activities and made certain acquisitions in
anticipation of that financing being completed. Options are being considered and
action has been taken relative to this failed capital commitment.

The total revenues of the Company declined by approximately $329,000 in the
quarter from consolidated revenues of $1,016,384 during the quarter ended June
30, 2000 to $686,526 for the period ended June 30, 2001. In addition revenue
declined by 14.5% as compared to the first quarter of 2001. This decline is due
in part to the continued negative impact of eliminating a provider service
within Healthcare in late 2000 and the effect of relocating several of the
practice sites in 2000. In addition the Continua/Emdx subsidiary experienced a
41.1% decline in revenue going from $287,531 in the quarter ended June 30, 2000
to $169,281 in the quarter ended June 30, 2001. This decline is directly related
to a contract which was not renewed in fiscal 2001. It is expected that new
contracts initiated in fiscal 2001 will replace this lost revenue during the
last six months of the fiscal year. Revenue from product sales also declined by
approximately $9,000 from $42,989 in the period ending June 30, 2000 to $33,824
in the period ending June 30, 2001. This continued decline in revenue reflects
the inability to market products resulting from the lack of capital resources.
Product sales will continue to decline unless and until new capital is raised.


-7-

<PAGE>

Selling and Administrative Expenses declined by 11.1% from June 30, 2000 to June
30, 2001. Management believes this decline represents the variable expenses
related to declining revenues. Expenses are at or near a fixed base given the
continued operation of the current foundation of clinical operations and
services.

Liquidity  and  Capital  Resources

A previously announced financing expected to close by May of this year did not
materialize. Management has been negotiating with various sources as a
replacement to the previous source of capital. There is no assurance that any of
these sources will be able to fund the Company at the level or in the time frame
required to avoid substantial erosion of the foundation.

The significant increase in assets is accounted for by goodwill booked as a
result of the acquisitions made earlier in the fiscal year. Other assets, long
and short term, increased from a combined $1,125,088 in the period ending June
30, 2000 to $1,627,239 for the period ending June 30, 2001. This is primarily
the result of pre-payment for consulting services which were made with the
Company's common stock. The Company has notified the consultant of the intent to
cancel the agreement and has demanded return of all shares. The asset will be
carried on the books until the dispute has been resolved.

Total current liabilities increased by approximately $117,340 from $5,817,766 in
the period ending December 31, 2000 to $5,935,106 in the period ending June 30,
2001. This is largely accounted for by an increase in accounts payable resulting
from the lack of capital.

There were no purchases or disposals of fixed assets during the period other
then in the normal course of business.

The cash used in operations for the three months ended June 30, 2001 and 2000
was $108,533 and $17,051 respectively.

Cash flow shortages continue to demand the attention of management and have had
a stifling affect on the Company's ability to take advantage of its foundational
infrastructure. The Company anticipates negative cash flows from operations to
continue through the end of the current fiscal year and will experience further
sales declines of its nutritional products due to the inability to replenish
certain inventory. Management believes that additional funding will be necessary
in order for it to continue as a going concern. In February, the Company
initiated an offering to sell shares of Series B Convertible Redeemable
Preferred Stock. Successful completion of this offering is expected to bring
$10,000,000 to the company before selling costs although there can be no
assurances that the Company will be successful in procuring such financing. The
Preferred Offering carries a conversion to common stock, which, if fully
converted will result in the issuance of 4,000,000 shares. The is a coupon of
10% payable quarterly. The Company has sold a quarter of one unit to date.


                                      -8-

<PAGE>

                           PART II - OTHER INFORMATION

ITEM 1.  LEGAL  PROCEEDINGS.

In July 2001 the Company has settled a law suit previously brought Raymond J.
Rousseau and Theresa Rousseau. The terms require the company to make payments
under a long term note. The impact of the settlement will not have a material
impact on the Company and will be reflected in the subsequent reporting period.
Other unsettled actions previously disclosed remain pending.

In April a subsidiary of the Company, Access HealthMax, Inc., received notice of
a law suit filed in Hamilton County, Ohio by KGBN, Inc. The action relates to a
dispute surrounding a contract for the establishment of a nutritional center by
Plaintiff. The Company is review its options in the matter

In July a subsidiary of the Company, Access HealthMax, Inc., received notice of
a law suit filed in El Paso County, Colorado by Mr. Brent Phillips. The
Plaintiff seeks, among other things, repayment of a loan made Access HealthMax,
Inc. The Company is review its options in the matter


ITEM 2.  CHANGES  IN  SECURITIES

n/a

ITEM 3.  DEFAULTS  UPON  SENIOR  SECURITIES

Access HealthMax, Inc. continues to be in violation of its loan agreements and
will be unable to pay interest and principle until new capital has been raised.

ITEM 4.  SUBMISSION  OF  MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS

n/a

ITEM 5.  OTHER  INFORMATION.

n/a

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

n/a


                                      -9-

<PAGE>

                                   SIGNATURES


In accordance with the requirements of the Exchange Act, the Company caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized.


                                        ACCESS  HEALTH  ALTERNATIVES, INC.


         Date:   8/13/01                /s/ Daniel  J.  Pavlik
                                        ----------------------------------
                                        Daniel J. Pavlik, President  &  CEO


         Date:   8/13/01                 /s/ Steven  Miracle
                                         -----------------------------------
                                         Steven Miracle, Chief Operating Officer





                                      -10-